低剂量阿米苏普里德与奥兰扎宾-弗洛克塞丁组合在精神分裂后抑郁症中的有效性和安全性:一项随机对照试验
相关实验视频
Updated: Jun 29, 2025

05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
37.3K
Tathagata Biswas1, Biswa Ranjan Mishra1, Rituparna Maiti2
1Department of Psychiatry, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Journal of psychiatric research
|April 1, 2024
概括
低剂量阿米苏普利德有效治疗后精神分裂性抑郁症 (PSD),具有有利的安全性,可与奥兰扎-素组合相比较. 这一发现为PSD患者提供了潜在的单疗法选择.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床神经科学 临床神经科学
背景情况:
- 后精神分裂症抑郁症 (PSD) 显著增加精神分裂症患者的发病率和死亡率.
- 对PSD有效的治疗选择有限,缺乏实质性的临床实践证据.
- 这项研究解决了PSD中基于证据的治疗策略的需要.
研究的目的:
- 为了比较低剂量阿米苏普利德与奥兰扎-素组合 (OFC) 在治疗PSD中的疗效和安全性.
- 评估这些治疗对抑郁症严重程度和血清BDNF水平的影响.
- 为了确定PSD的潜在单疗法选择.
主要方法:
- 一项随机对照试验,涉及60名患有PSD的患者.
- 随机分配患者接受低剂量阿米苏普利 (100-300毫克/天) 或OFC (5/10毫克+20毫克) 八周.
- 评估包括卡尔加里精神分裂症抑郁量表 (CDSS),临床全球印象严重性 (CGI-S) 和血清BDNF水平.
主要成果:
- 与基线相比,阿米苏普里德和OFC组的CDSS和CGI-S得分均显著改善.
- 在阿米苏普里德和OFC组之间没有观察到治疗结果的显著差异.
- 在CDSS得分变化和血清BDNF水平之间发现了显著的负相关性;没有报告的显著不良事件.
结论:
- 低剂量阿米苏普利显示出作为PSD单一治疗的潜力,表现出良好的临床结果和安全性.
- 在这项研究中,低剂量阿米苏普利德的疗效和安全性似乎与OFC相似.
- 进一步的研究可能会支持阿米苏普里德作为精神分裂后抑郁症的首要治疗方法.
更多相关视频
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
228
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
228
Psychosis: Goals of Pharmacotherapy
125
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
125
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
382
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
382
Psychosis and Antipsychotic Drugs: Overview
248
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
248
Mania and Antimanic Drugs: Overview
176
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
176

